Concepedia

Chris Freeden

CF

Statistics

Publications

8

Citations

361

H-Index

8

Active since

1999

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Biocon (India)

Chris Freeden is an author at Bristol-Myers Squibb (Germany) specializing in pharmacology, medicine, and drug discovery.

Publications per year

1999–2016

8

Publications

8

Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species

Hong Shen, T. Liu, Yaofeng Cheng et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 114 citations

, , +9

Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 1. <i>N</i>-Cyanoguanidine Bioisosteres Possessing in Vivo Bladder Selectivity

John A. Butera, Madelene Antane, Schuyler Antane et al. · Journal of Medicinal Chemistry · 2000 · 79 citations

, , +17

Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 2. Selective and Potent Benzylamino Cyclobutenediones

A. Gilbert, Madelene Antane, Thomas M. Argentieri et al. · Journal of Medicinal Chemistry · 2000 · 53 citations

, , +15

Comparison of the Potassium Channel Openers, WAY-133537, ZD6169, and Celikalim on Isolated Bladder Tissue and In Vivo Bladder Instability in Rat

Alexandra Wojdan, Chris Freeden, Morgan Woods et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 49 citations

, , +16

Identification of a Nonbasic Melanin Hormone Receptor 1 Antagonist as an Antiobesity Clinical Candidate

William N. Washburn, Mark C. Manfredi, Pratik Devasthale et al. · Journal of Medicinal Chemistry · 2014 · 20 citations

, , +8

1–5 of 8